Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2004
05/20/2004US20040097729 Substituted pyridine herbicides
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097579 Taxane formulations
05/20/2004US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
05/20/2004US20040097564 Method and compounds for treating glaucoma VI
05/20/2004US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents
05/20/2004US20040097560 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
05/20/2004US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
05/20/2004US20040097545 Quinolinone derivatives
05/20/2004US20040097532 3-Substituted oxindole beta 3 agonists
05/20/2004US20040097531 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia
05/20/2004US20040097513 Novel non-imidazole compounds
05/20/2004US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/20/2004US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor
05/20/2004US20040097501 Triazole compounds useful as protein kinase inhibitors
05/20/2004US20040097487 To inhibits matrix metalloprotease activity
05/20/2004US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists
05/20/2004US20040097480 For use as chemical intermediates for the synthesis of oligopeptide analogues including HIV (Human Immunodeficiency Virus) protease inhibitors
05/20/2004US20040097471 For therapy and prophylaxis of influenza infection
05/20/2004US20040097461 Methods and compositions for treating hepatitis C Virus
05/20/2004US20040097438 Fused-ring compounds and use thereof as drugs
05/20/2004US20040096787 Color photography
05/20/2004US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm.
05/19/2004EP1420303A2 Organophotoreceptor with charge transport compound having an epoxy group
05/19/2004EP1419770A1 Apo ai expression accelerating agent
05/19/2004EP1419154A1 Rapamycin 29-enols
05/19/2004EP1419153A1 Rapamycin dialdehydes
05/19/2004EP1419152A1 Hiv inhibiting pyrimidines derivatives
05/19/2004EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
05/19/2004EP1273575B1 Diazepane derivatives or salts thereof
05/19/2004EP1110951B1 Pyrimidine derivatives
05/19/2004EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
05/19/2004EP1060176B1 Oxyranyle-triazoline thiones and their use as microbicides
05/19/2004EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors
05/19/2004EP1020453B1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
05/19/2004EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/19/2004EP0888323B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/19/2004EP0781136B1 Compounds and methods for the treatment of cancer
05/19/2004EP0722936B1 Fused pyridazine compound
05/19/2004EP0717736B1 Phosphorus derivatives to treat aids
05/19/2004DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer
05/19/2004DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
05/19/2004CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
05/19/2004CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor
05/19/2004CN1498210A MCH antagonists and their use in treatment of obesity
05/19/2004CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands
05/19/2004CN1498208A Carboxamides as fungicides in agriculture
05/19/2004CN1496988A 2-(4-methiophnoxy)-5-furfural imidazolone derivative with bactericiding activity
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150192C Piperidines as CCR5 modulators
05/19/2004CN1150191C Aminoalkyl substituted benzodioxan derivatives
05/19/2004CN1150190C 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders
05/19/2004CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors
05/19/2004CN1150187C Use of selective antagonists of a1b-adrenergic receptor for improvement of sexual dysfunction
05/19/2004CN1150183C New heterocylic tertiary amines, process for their preparation and pharmaceutical compositions containing them
05/19/2004CN1150181C Substituted benzopyran analogs for treatment of inflammation
05/19/2004CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors
05/19/2004CN1150178C Sidechain-bearing taxanes
05/19/2004CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them
05/19/2004CN1150167C Indole derivatives
05/19/2004CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders
05/19/2004CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia
05/18/2004US6737440 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles
05/18/2004US6737422 Voltage-dependent
05/18/2004CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof
05/13/2004WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use
05/13/2004WO2004039995A1 Mutagenesis methods using ribavirin and/or rna replicases
05/13/2004WO2004039798A1 Quaternary ammonium compounds and their use as antimuscarinic agents
05/13/2004WO2004039795A2 Amide compounds for the treatment of hyperlipidemia
05/13/2004WO2004039784A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
05/13/2004WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
05/13/2004WO2004039367A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
05/13/2004WO2004026305A9 Diaryl ethers as opioid receptor antagonist
05/13/2004WO2004020431A3 Novel benzoimidazole derivatives useful as antiproliferative agents
05/13/2004WO2002055013A8 Therapeutic chromone compounds
05/13/2004WO2002048102A3 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses
05/13/2004US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
05/13/2004US20040092746 Fungicides
05/13/2004US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
05/13/2004US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration
05/13/2004US20040092628 Heat and oxidation resistance; photostability; for automobile coatings, candle wax
05/13/2004US20040092604 Amino-tetralin derivatives as muscarinic receptor antagonists
05/13/2004US20040092579 Central nervous system diosrders; catalytic hydrogenation
05/13/2004US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
05/13/2004US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
05/13/2004US20040092556 Aids therapy
05/13/2004US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
05/13/2004US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
05/13/2004US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease
05/13/2004US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same
05/13/2004US20040092521 Antihistamines; central nervous system disorders
05/13/2004US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors
05/13/2004US20040092513 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
05/13/2004US20040092507 Melanocortin receptor agonists
05/13/2004US20040092505 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
05/13/2004US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists
05/13/2004US20040092436 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins
05/13/2004US20040092402 Pyrimidine derivatives and herbicides containing the same
05/13/2004US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme
05/13/2004US20040088802 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors